Biofilms and Immunity in Chronic Wounds
慢性伤口中的生物膜和免疫
基本信息
- 批准号:8414015
- 负责人:
- 金额:$ 42.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAntibioticsArchitectureBacteriaBacterial InfectionsBurn injuryCellsCharacteristicsChronicClinicalCommunitiesDataDebridementDevelopmentDiseaseDoseEndocarditisFamilyFamily suidaeFutureGenomicsHealthHealthcareHost DefenseHumanImmuneImmune responseImmune systemImmunityImpaired wound healingIn VitroIndividualInfectionInflammatoryKineticsLinkMethodsMicrobeMicrobial BiofilmsMissionModelingMolecularMolecular ProfilingNatural ImmunityOperative Surgical ProceduresOrganismPatientsPopulationPseudomonas aeruginosaPublic HealthResistanceSamplingSiteStaphylococcus aureusSwimmingTestingThickTimeTissuesTraumaWorkWound HealingWound InfectionWounds and Injuriesantimicrobialbasecytokinedensitydesignefficacy testinghuman tissueimmune clearanceimprovedin vitro Modelinformation gatheringinsightkillingsmicrobialnon-genomicnovel strategiespathogenresearch studyresponsetreatment strategywound
项目摘要
DESCRIPTION (provided by applicant): This application seeks to address the impact of bacterial colonization and persistence in chronic wounds. The formation of biofilms has clearly been linked to chronic and persistent bacterial infections. This considerably delays and complicates wound healing. Unlike acute bacterial infections, which are often cleared by the host, biofilm-related chronic infections are not easily resolved even with high dose antibiotics and intact immunity. The bacterial pathogens Pseudomonas aeruginosa and Staphylococcus aureus, which are the focus of this application, cause an array of biofilm-related clinical diseases including persistent airway infections, burn wound infections, endocarditis, and surgical site infections. Unresolved infected wounds also contribute to nosocomial persistence and the spread of bacteria in health care settings. The abundance and persistence of chronic infections due to biofilm formation has led to the hypothesis that biofilms deploy directed mechanisms to subvert recognition, activation, and functions of the host immune system. This proposal will use state-of-the- art molecular and genomic approaches to better understand the impact of bacterial colonization in chronic wounds. Aim 1 will define mechanisms by which P. aeruginosa and S. aureus resist killing by host-derived antimicrobials and innate immune cells. Aim 2 will utilize a newly developed porcine full thickness burn chronic wound model and explanted human tissue from burn wound debridement to investigate biofilm persistent infections caused by P. aeruginosa and S. aureus. The development of a chronic infection model that can be sampled over time as well as access to materials derived from humans suffering burn-wound injury provides a relevant, unique, and novel approach for examining the effects of biofilm formation in the host. Conclusions made from in vitro data will be efficiently tested in the porcine model and human tissue for applicability in clinical infection. Ultimately information gathered will aid the treatment of an array of chronic infections including highly prevalent persistent wound infections.
PUBLIC HEALTH RELEVANCE: Pseudomonas aeruginosa and Staphylococcus aureus are versatile opportunistic pathogens that can cause devastating persistent wound infections. Within the wound, these organisms transform into a resistant community called a biofilm. Biofilm-related chronic infections are not easily resolved even with high dose antibiotics and intact immunity. This application will use molecular and genomic approaches to define how biofilm-growing bacteria resist antibiotics and host immune cells. This will allow us to better understand the impact of bacterial colonization in chronic wounds and aid future management and treatment of chronic infections that significantly impact human health.
描述(由申请人提供):本申请旨在解决慢性伤口中细菌定植和持久性的影响。生物膜的形成显然与慢性和持续性细菌感染有关。这大大延迟了伤口愈合并使其复杂化。与通常由宿主清除的急性细菌感染不同,即使使用高剂量抗生素和完整的免疫力,生物膜相关的慢性感染也不容易解决。细菌病原体铜绿假单胞菌和金黄色葡萄球菌是本申请的焦点,它们引起一系列生物膜相关的临床疾病,包括持续性气道感染、烧伤伤口感染、心内膜炎和手术部位感染。未解决的感染伤口也有助于医院的持久性和细菌在卫生保健环境中的传播。由于生物膜形成导致的慢性感染的丰富性和持久性导致了生物膜部署定向机制以破坏宿主免疫系统的识别、激活和功能的假设。该提案将使用最先进的分子和基因组方法来更好地了解细菌定植在慢性伤口中的影响。目的1将明确铜绿假单胞菌和S。金黄色葡萄球菌抵抗宿主来源的抗微生物剂和先天免疫细胞的杀伤。目的二是利用新建立的猪Ⅲ度烧伤慢性创面模型和烧伤创面清创后的组织标本,研究铜绿假单胞菌和沙门氏菌引起的生物膜持续性感染。金黄色。可以随时间采样的慢性感染模型的开发以及获得来自遭受烧伤-创伤损伤的人的材料提供了用于检查生物膜形成在宿主中的影响的相关的、独特的和新颖的方法。根据体外数据得出的结论将在猪模型和人体组织中进行有效测试,以确定临床感染的适用性。最终,收集的信息将有助于治疗一系列慢性感染,包括高度流行的持续性伤口感染。
公共卫生相关性:铜绿假单胞菌和金黄色葡萄球菌是多功能的机会致病菌,可引起破坏性的持续性伤口感染。在伤口内,这些生物体转化为称为生物膜的抗性群落。生物膜相关的慢性感染即使使用高剂量抗生素和完整的免疫力也不容易解决。该应用将使用分子和基因组方法来定义生物膜生长细菌如何抵抗抗生素和宿主免疫细胞。这将使我们能够更好地了解慢性伤口中细菌定植的影响,并有助于未来管理和治疗严重影响人类健康的慢性感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chandan K Sen其他文献
Chandan K Sen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chandan K Sen', 18)}}的其他基金
Cell Specific Gene Editing to Close Diabetic Wounds
细胞特异性基因编辑闭合糖尿病伤口
- 批准号:
10628884 - 财政年份:2023
- 资助金额:
$ 42.21万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7382693 - 财政年份:2008
- 资助金额:
$ 42.21万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7547006 - 财政年份:2008
- 资助金额:
$ 42.21万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7994839 - 财政年份:2008
- 资助金额:
$ 42.21万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7752535 - 财政年份:2008
- 资助金额:
$ 42.21万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant